MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurdal, H.
Right arrow Articles by Friedman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurdal, H.
Right arrow Articles by Friedman, E.

Vol. 52, Issue 6, 1064-1070, 1997

Role of Galpha q or Galpha o Proteins in alpha 1-Adrenoceptor Subtype-Mediated Responses in Fischer 344 Rat Aorta

Hakan Gurdal, Tammy M. Seasholtz, Hoau-Yan Wang, R. Dale Brown, Mark D. Johnson, and Eitan Friedman

Department of Pharmacology, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania (H.G., T.S., H.Y.W., M.D.J., E.F.), Department of Pharmacology, the Medical School of Ankara University Ankara, Turkey (H.G.), and Research and Development Service, Edward Hines Jr. Veterans' Administration Hospital, Hines, Illinois (R.D.B.)

    Summary
Top
Summary
Introduction
Procedures
Results
Discussion
References

Previous studies showed that alpha -adrenoceptor (AR) stimulation with norepinephrine is more potent at eliciting contraction in aortas from 1-month-old Fischer 344 rats than from older rats and that this response is mediated by alpha 1b- and alpha 1d-AR subtypes in 1-month-old rats. We examined the G proteins responsible for alpha 1-AR-mediated contractile response and inositol phosphate accumulation in the aortas of 1-month-old Fischer 344 rats. Pertussis toxin (PTX) treatment (2.5 µg/ml for 4 hr) of aortic rings partially inhibited phenylephrine (PHE)-stimulated contraction and inositol phosphate accumulation, suggesting the involvement of PTX-sensitive and -insensitive G proteins. Specific antisera directed against Galpha q and Galpha o but not Galpha s and Galpha i precipitated specific alpha 1-AR binding sites labeled with 2-[beta -(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl]tetralone. The number of 2-[beta -(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl]tetralone binding sites precipitated by Galpha proteins was increased by activating membrane alpha 1-ARs with PHE. Moreover, PHE stimulated the palmitoylation of Galpha q and Galpha o, and this response was blocked by the alpha 1-AR antagonist prazosin. Characterization of the alpha 1-AR subtypes that couple to G proteins indicates that although aortic alpha 1a-, alpha 1b-, and alpha 1d-ARs were associated with Galpha q, alpha 1b-AR was also linked to Galpha o. These results suggest that alpha 1-ARs mediate the contractile response in rat aorta by coupling to both Gq protein and the PTX-sensitive Go protein.

    Introduction
Top
Summary
Introduction
Procedures
Results
Discussion
References

Three alpha 1-AR subtypes (alpha 1a, alpha 1b, and alpha 1d) have been cloned, and mRNA for each has been detected in the rat aorta (1, 2). The specific role of each alpha 1-AR subtype in regulating vascular smooth muscle function has not been completely established. When overexpressed in cultured cells, each of the subtypes has been shown to be capable of eliciting characteristic alpha 1-adrenergic responses, including activation of PLC and increased intracellular calcium (3, 4). Several studies have shown that alpha 1-ARs can couple to Gq and activate phospholipase C, resulting in production of inositol trisphosphate and release of intracellular calcium (5). However, it has been shown that alpha 1-AR-mediated contractile responses in vascular smooth muscle are partially inhibited by PTX treatment, suggesting the involvement of both PTX-sensitive and -insensitive G proteins in the contractile response (6-8). Thus, in vascular smooth muscle, it is not clear what combination of endogenous alpha 1-AR subtypes and G proteins is responsible for activating PLC and eliciting the contractile response.

In previous studies, we showed that although aortas from 1-month-old Fischer 344 rats express alpha 1a-, alpha 1b-, and alpha 1d-ARs, the contractile response to NE is mediated by stimulation of the alpha 1b- and alpha 1d-ARs (9, 10). NE produced a more potent contractile response in these aortas compared with aortas of older rats, in which the expression and functional role of the alpha 1a-AR increase (9, 11). The determination of the coupling of alpha 1-AR subtypes to specific G proteins will facilitate understanding of the functional roles of alpha 1-AR subtypes in the aorta; therefore, the aim of the current study was to define alpha 1-AR/G protein coupling in aortic membranes. This was achieved by examining the sensitivity of alpha 1-AR-mediated responses to PTX treatment; assessing alpha 1-ARs that coimmunoprecipitated with Galpha proteins using specific antisera directed against Galpha subunits, Galpha proteins that coimmunoprecipitated with alpha 1-AR subtypes using specific antisera directed against alpha 1-AR subtypes; and examining alpha 1-AR-stimulated palmitoylation of alpha  subunits or receptor-stimulated changes in coprecipitation of alpha 1-AR binding sites with Galpha subunits in aortic membranes.

    Experimental Procedures
Top
Summary
Introduction
Procedures
Results
Discussion
References

Animals. One-month-old male Fischer 344 rats were obtained from National Center for Toxicological Research (Jefferson, AR), where they are bred and maintained under the auspices of the National Institute on Aging. On receipt at our institution, animals were maintained for 1-2 weeks under barrier conditions comparable to those under which they were raised.

Contraction. Rats were killed through decapitation, and the aorta was removed and placed in ice-cold PSS composed of 120 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 1.0 mM NaH2PO4, 25 mM NaCO3, 1.8 mM CaCl2, 11 mM glucose, and 0.024 mM EDTA. Vessels were cleansed of fat and connective tissue and cut into 3-mm-wide rings. Aortic ring segments were mounted at 37° in 15-ml organ baths using stainless steel hooks connected by fine gold chain at the bottom to a stationary glass rod attached to the bath and at the top to a Grass Instruments (Quincy, MA) model FT0.03 force-displacement transducer and bubbled continuously with 95% O2/5% CO2. Responses were recorded on a Grass model 7 polygraph. Rings were equilibrated for 1 hr at a previously optimal resting tension of 1.5 g. Concentration-response curves were determined through cumulative increases in the concentration of agonist. Rings then were washed extensively by several changes of PSS over 1-2 hr until tension stabilized at the precontraction level. For experiments with PTX, rings were incubated with the toxin for 4 hr in PSS. Then, the rings were washed for 1 hr with several changes of PSS, and cumulative concentration-response curves to PHE were obtained.

IP accumulation. The method used for measuring [3H]inositol metabolism was described previously (12, 13). Aortic rings were prepared as described above and then preincubated in oxygenated buffer composed of 122 mM NaCl, 4.9 mM KCl, 1.2 mM MgCl2, 1.2 mM KH2PO4, 3.6 mM NaCO3, 1.3 mM CaCl2, 11 mM glucose, and 30 mM HEPES, pH 7.4, at 37° for 1 hr. Subsequently, artery segments were incubated for 1.5 hr in buffer containing 20 µCi/ml of myo-[3H]inositol (17 Ci/mmol; New England Nuclear Research Products, Boston, MA) under the same conditions. Labeled artery segments were washed four times and placed inot individual tubes containing buffer with 10 mM LiCl (total assay volume, 300 µl). Treatment with PTX was as described above. Incubation with agonist was for 60 min with oxygenation at 15-min intervals and was stopped by the addition of 300 µl of ice-cold 15% trichloroacetic acid and then left on ice for 15 min. The tubes were centrifuged (1500 × g for 10 min), and aliquots (350 µl) of supernatant were added to 125 µl of 10 mM EDTA in 1.5-ml microcentrifuge tubes, followed by 500 µl of 1:1 Freon/tri-n-octylamine. The samples were vortexed and left to stand for 10 min before centrifugation (12,000 × g for 10 min), and 350 µl of upper aqueous phase was taken for analysis of IPs. Samples were loaded onto Dowex-1(X8) ion exchange columns (formate form, 100-200 mesh, 1 ml). The columns were washed initially with 16 ml of myo-[3H]inositol (5 mM). Then, IPs were eluted with 4 ml of 0.1 M formic acid/1 M ammonium formate. Radioactivity was measured by liquid scintillation counting.

Preparation of aortic membrane. Rats were killed by decapitation, and the aorta was removed; placed in 20 mM NaH2PO4-Na2HPO4 buffer (pH 7.6) containing 154 mM NaCl, 0.5 mM phenylmethylsulfonyl fluoride, 25 µg/ml leupeptin, 20 µg/ml aprotinin, and 25 µg/ml pepstatin; cleansed of fat and connective tissue; homogenized using a glass-to-glass homogenizer; and centrifuged at 500 × g for 10 min at 4°. The supernatant was centrifuged at 100,000 × g for 60 min at 4°. The resulting pellet was resuspended, rehomogenized, and then recentrifuged under the same conditions. The final pellet was resuspended in PBS. Protein content was measured according to the method of Bradford (14).

Solubilization of aortic membrane. Aortic membranes were solubilized by modification of a previously described procedure (15). Briefly, aortic membranes were prepared as described above. They were then solubilized by gentle end-over-end shaking for 60 min at 4° in PBS containing 1.5% digitonin, 0.5 mM phenylmethylsulfonyl fluoride, 25 µg/ml leupeptin, 20 µg/ml aprotinin, and 25 µg/ml pepstatin. The sample was centrifuged at 100,000 × g for 60 min at 4°, and the supernatant was used for the soluble fraction of the membrane. The pellet was also collected for determination of the insoluble alpha 1-ARs and G protein alpha  subunits remaining in the membranes. The solubilized alpha 1-ARs were detected by measuring [125I]HEAT binding. The samples were incubated with a 300-400 pM concentration of [125I]HEAT for 60 min at 37°. Reactions were terminated by rapid filtration using a Brandel (Montreal, Quebec, Canada) cell harvester and Whatman (Clifton, NJ) DE81 filters to trap the solubilized proteins. Filters were washed four times with 4 ml of ice-cold PBS. The filter-bound radioactivity was determined in a Beckman Instruments (Palo Alto, CA) gamma -counter. Nonspecific binding was defined as binding in the presence of 0.1 µM prazosin or 1 mM NE with identical results. Assays were conducted in duplicate. After solubilization of aortic membranes, 20-30% of the initial alpha 1-AR binding was detected in soluble fraction.

Immunoprecipitation of G protein alpha  subunits and alpha 1-AR subtypes. Solubilized G protein alpha  subunits were immunoprecipitated as described previously (15, 16). Soluble membrane protein (10-15 fmol of alpha 1-AR) was incubated with an appropriate dilution of Galpha -specific antiserum overnight in a rotatory shaker at 4°C. Nonimmune serum at the same dilution was used as a control. Appropriate dilution was determined when no further immunoprecipitation was observed at a higher concentration of the antiserum (maximum concentration, 1:50). Then, 100 µl of a 1:1 suspension of protein A/Sepharose beads (CL-4B: Sigma Chemical, St. Louis, MO), prewashed three times and diluted in PBS, was added to the samples and incubated overnight in a rotary shaker at 4°C. The samples were centrifuged at 10,000 × g for 3 min; the supernatant was collected to measure remaining alpha 1-ARs; and the pellet was resuspended in PBS and recentrifuged as described above. The immunoprecipitate was resuspended in PBS, and alpha 1-ARs were detected by measuring [125I]HEAT binding as described above. In some samples, the immunoprecipitate was separated on 10% SDS-polyacrylamide gels, transferred to nitrocellulose membrane, and immunoblotted with anti-Galpha antisera to confirm the identity of the precipitated G protein alpha  subunits. In several experiments, the immunoprecipitate was incubated with 0.1 mM guanosine-5'-(beta ,gamma -imido)triphosphate for 60 min at 25° and then centrifuged at 10,000 × g for 3 min. The pellet was resuspended in PBS, and alpha 1-ARs in the immunoprecipitate were determined using the radioligand binding assay described above.

In a separate experiment, aortic membranes (400 µg) were solubilized by and incubated with antisera directed against the alpha 1a-, alpha 1b-, or alpha 1d-ARs (1:250 dilution) for 3 hr followed by a 60-min incubation with 100 µl of a 10% suspension of protein A, bearing Staphylococcus aureus cells (Pansorbin cells; Calbiochem, San Diego, CA). Initial characterization of these antibodies has been reported previously (17). After centrifugation and washing, the immunoprecipitates were solubilized in sample preparation buffer (62.5 mM Tris·HCl, pH 6.8, 10% glycerol, 2% SDS, 5% 2-mercaptoethanol, 0.1% bromphenol blue), and proteins were separated by 10% SDS-polyacrylamide gel electrophoresis, transferred electrophoretically to a nitrocellulose membrane, and immunoblotted with polyclonal antibody against Galpha proteins (1:2000 in 0.1% Tween-20 in PBS). In some samples, the selectivity of the antisera directed against alpha 1a-, alpha 1b-, or alpha 1d-ARs, and the effectiveness of the immunoprecipitation was tested. The immunoprecipitates were separated on 10% SDS-polyacrylamide gels, transferred to nitrocellulose membranes, and immunoblotted with anti-alpha 1a-, -alpha 1b-, or -alpha 1d-AR antisera to test the identity and the amount of the precipitated alpha 1-AR subtype.

Immunoblots. Aortic membranes, solubilized membranes, or membrane immunoprecipitates were subjected to 10% SDS-polyacrylamide gel electrophoresis (18) and then transferred electrophoretically to nitrocellulose. Immunoblotting was performed using antisera for alpha  subunits of G proteins [RM/1 (Galpha s), AS/7 (Galpha i), GC/2 (Galpha o), QL (Galpha q/11); dilution 1:2000; New Nuclear England Research Products] and ECL as described previously (15, 19). Briefly, nitrocellulose membranes were incubated overnight at 4° in PBS containing 3% bovine serum albumin and 8% nonfat dry milk. Blots were washed several times with 0.1% TBS and then incubated with antisera at room temperature for 1-2 hr with shaking. Blots were then washed four times (10 min each) with 0.1% TBS and then incubated with 1:10,000 dilutions of horseradish peroxidase-labeled donkey anti-rabbit IgG or rabbit anti-goat (alpha 1a-AR) in 0.1% TBS for 1 hr at room temperature. Blots were washed once with 0.3% TBS for 30 min followed by four 5-min washes with 0.1% TBS and then incubated with ECL Western blotting reagent (SuperSignal substrate, Western Blotting; Pierce, Rockford, IL) for 4 min and exposed to X-ray film for 15-45 sec.

Agonist-induced palmitoylation of Galpha proteins. Aortas were homogenized and centrifuged (500 × g for 10 min at 4°) as described above except with HEPES buffer containing 25 mM HEPES, pH 7.4, and 2 mM EGTA. The supernatant was centrifuged at 100,000 × g for 60 min at 4°. The resulting pellet was resuspended, rehomogenized, and then recentrifuged under the same conditions. The final pellet was resuspended in oxygenated Krebs-HEPES buffer containing 25 mM HEPES, pH 7.4, 154 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgCl2, 0.2% 2-mercaptoethanol, 25 µg/ml leupeptin, 25 µg/ml pepstatin A, 0.01unit/ml soybean trypsin inhibitor, and 0.05 mM phenylmethylsulfonyl fluoride and used as the crude membrane preparation. The assay mixture (250 µl) containing 200 µg of membrane protein, 800 µCi/ml [9,10-3H]palmitic acid (specific activity, 50 Ci/mmol; New Nuclear England Research Products) was incubated at 37° for 10 min followed by an additional 5-min incubation with either buffer or agonist. To test the specificity of this receptor mediated response, membranes were incubated with a selective alpha 1-AR antagonist for 5 min before the addition of the agonist. The reaction was terminated by dilution with 750 µl of ice-cold Krebs-HEPES containing 1 mM EGTA, mixed, placed on ice, and immediately centrifuged at 16,000 × g for 30 min in microcentrifuge. The pellets were solubilized in 1.5 ml of Krebs-HEPES buffer containing 1.5% digitonin, and soluble membrane proteins were immunoprecipitated using antisera directed against the Galpha proteins as described above. The radioactivity in the immunoprecipitate was measured by liquid scintillation counting. The radioactivity precipitated by the normal rabbit serum was considered background and subtracted from all values.

Data analysis. Differences were determined by ANOVA and post hoc analysis for multiple comparisons. A value of p < 0.05 was considered significant.

Materials. For these studies, pargyline HCl, soybean trypsin inhibitor, and the buffer reagents were purchased from Sigma. The chemicals used for IP isolation and determination were purchased from Fisher Scientific (Pittsburgh, PA). PHE was purchased from Research Biochemicals (Natick, MA). Normal rabbit serum and Pansorbin were purchased from Calbiochem. Prazosin HCl was generously supplied by Pfizer (New York, NY). [9,10-3H]Palmitic acid (50 Ci/mmol), [125I]HEAT (2200 Ci/mmol), and the antisera to Galpha s (RM/1), Galpha i(1,2) (AS/7), Galpha o (GC/2), and Galpha q/11 (QL) were purchased from New Nuclear England Research Products. Antisera to alpha 1b- and alpha 1d-ARs were produced by one of the authors (R.D.B.). Antiserum to alpha 1a was purchased from Santa Cruz Biochemicals (Santa Cruz, CA). Horseradish peroxidase-labeled donkey anti-rabbit IgG or rabbit anti-goat (SuperSignal substrate, Western Blotting; Pierce).

    Results
Top
Summary
Introduction
Procedures
Results
Discussion
References

Effect of PTX on contraction and IP accumulation. PTX treatment maximally inhibited PHE-induced contractile response at a concentration of 2.5 µg/ml (Fig. 1). Higher PTX concentrations did not cause further inhibition in the responses to PHE, and KCl-induced contraction was not altered by PTX treatment (data not shown). PHE-induced IP accumulation was also inhibited (52 ± 8%) by 2.5 µg/ml PTX treatment (Fig. 2).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   PHE-induced contraction of aortic ring segments in 1-month-old Fischer 344 rats before (bullet ) and after (black-square) treatment with PTX (2.5 µg/ml, 4 hr at 37°). Data represent mean ± standard error of determinations obtained from five or six animals. A significant reduction in PHE concentration-response curve was obtained after PTX treatment as determined by ANOVA followed by Newman-Keuls test for multiple comparisons (*, p < 0.05).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   PHE-stimulated IP accumulation in aortic ring segments from 1-month-old aorta before and after treatment with PTX (2.5 µg/ml, 4 hr at 37°). Aortic rings were labeled with myo-[3H]inositol and subjected to incubation with agonist ,and IPs were separated by ion exchange chromatography. Data represent mean ± standard error of determinations obtained from five or six animals. A significant reduction in PHE-activated IP accumulation was obtained after PTX treatment as determined by ANOVA followed by Newman-Keuls test for multiple comparisons (*, p < 0.05).

Coupling of G proteins and alpha 1-ARs. The possibility that alpha 1-ARs directly couple to G proteins was tested by coimmunoprecipitation of alpha 1-ARs with anti-Galpha protein antibodies. We have previously shown by immunoblot analysis the presence of single bands for Galpha o (39 kDa), Galpha i (41 kDa), and Galpha q (42 kDa) and two bands for Galpha s (45 and 52 kDa) in aortic membranes (15, 19). The results summarized in Fig. 3 demonstrate that antisera against Galpha q and Galpha o but not Galpha s or Galpha i, at dilutions of 1:200, precipitated specific alpha 1-AR binding sites labeled by the selective alpha 1-AR ligand [125I]HEAT. To confirm the specificity of the immunoprecipitation, the precipitates obtained using Galpha q and Galpha o antisera were subjected to immunoblot analyses. Galpha q and Galpha o antisera selectively precipitated the respective proteins (data not shown). The coupling of Galpha proteins to alpha 1-AR subtypes alpha 1a, alpha 1b, and alpha 1d was investigated by monitoring the Galpha proteins that were coimmunoprecipitated with specific antisera directed against the alpha 1-AR subtypes. Immunoprecipitates of the alpha 1-AR subtypes derived from 400 µg of solubilized aortic membranes were separated on SDS-polyacrylamide gels and blotted with antibodies against the Galpha proteins. Fig. 4, A and B, illustrates that alpha 1a-, alpha 1b-, and alpha 1d-AR antibodies coimmunoprecipitated Galpha q protein, whereas the alpha 1b-AR antibody also immunoprecipitated Galpha o protein. Densitometric analysis of the results indicate that ~4.5-6% of membrane Galpha q was found to be associated with alpha 1a-, alpha 1b-, and alpha 1d-ARs, whereas only 2.8% of Galpha o was linked to alpha 1b-AR. The specificity of the anti-receptor antisera and the effectiveness of the immunoprecipitation are presented in Fig. 5. The figure demonstrates that the antiserum for each of the receptor subtypes completely and selectively precipitated the respective protein. Furthermore, incubation of aortic membranes with 1 µM PHE was found to increase [125I]HEAT binding in immunoprecipitates of Galpha q and Galpha o proteins by 370% and 350%, respectively (Fig. 6). These receptor stimulation-induced increases in receptor/Galpha coupling were inhibited 70-80% by an equimolar concentration of the alpha 1-AR antagonist prazosin (Fig. 6). Thus, the data indicate that in aortic membranes, the alpha 1a- and alpha 1d-ARs are coupled to Galpha q protein and the alpha 1b-AR subtype is linked to both Galpha q and Galpha o proteins.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Immunoprecipitation of alpha 1-ARs by antisera to Galpha s, Galpha o, Galpha q, and Galpha i and by nonimmune serum (NIS) in solubilized aortic membranes from 1-month-old rat. Soluble membrane proteins were incubated with antisera directed against the Galpha proteins, and immuncomplexes were precipitated with protein A/Sepharose beads. The alpha 1-ARs were detected by measuring [125I]HEAT binding in the precipitate. Each value represents the mean ± standard error of six or seven individual experiments. *, p < 0.05, significant difference by ANOVA followed by Newman-Keuls test for multiple comparisons.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   Coimmunoprecipitation of alpha 1-AR subtypes with Galpha proteins. Rat aortic membranes were solubilized and subjected to immunoprecipitation with anti-peptide antisera raised against alpha 1a-, alpha 1b-, or alpha 1d-AR (1:250 dilution). The immunocomplexes derived from 400 µg of solubilized aortic membranes were then solubilized and separated on 10% SDS-polyacrylamide gels, transferred onto nitrocellulose membranes, immunoblotted with specific Galpha antisera (1:2000 dilution), and detected by ECL. Galpha q was detected in alpha 1a-, alpha 1b-, and alpha 1d-AR immunoprecipitates (A and B), whereas Galpha o was observed only in the alpha 1b-AR immunoprecipitate (B). Lane C, immunoblots of 25 µg of solubilized aortic membranes. The immunoblots shown are representatives of four individual experiments that yielded similar results.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 5.   Specificity of the antisera to the alpha 1a-, alpha 1b-, and alpha 1d-ARs. The specificity of each of the alpha 1-AR antisera was tested in rat aortic membranes. Rat aortic membranes were solubilized, and 400 µg of protein was subjected to immunoprecipitation with antisera raised against alpha 1a-, alpha 1b-, or alpha 1d-ARs (1:250 dilution). Aliquots of solubilized immunocomplexes representing 50 µg of the original solubilized membrane preparation were separated on 10% SDS-polyacrylamide gels; transferred onto nitrocellulose membranes; immunoblotted with specific alpha 1a-, alpha 1b-, or alpha 1d-AR antisera (0.25 µg/ml for alpha 1a, 1:1000 dilution for alpha 1b or alpha 1d); and detected by ECL. Data indicate there was no cross-reactivity among the three antisera tested. Furthermore, the data indicate that immunoprecipitation with each of the antiserum resulted in >90% recovery of the specific alpha 1-AR subtype compared with the signal obtained from 50 µg of solubilized aortic membranes (lane C). Immunoblots are representative of three individual experiments that yielded comparable results.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 6.   Coupling of alpha 1-ARs to Galpha o and Galpha q in PHE-stimulated aortic membranes from 1-month-old rats. Aortic membranes were incubated with buffer or 1 µM PHE for 5 min. Tissues were solubilized, and membrane proteins were incubated with antisera directed against Galpha o or Galpha q proteins. Immuncomplexes were precipitated with protein A/Sepharose beads. In some experiments, aortic membranes were incubated with 1 µM concentrations of the selective alpha 1-AR antagonist prazosin for 5 min before the addition of buffer or PHE. The alpha 1-ARs in the immunoprecipitates were detected by measuring specific [125I]HEAT binding. Value represent the mean ± standard error of five individual experiments. PHE stimulation caused 370% and 350% increases in coupling of Galpha q and Galpha o proteins to alpha 1-ARs. Prazosin inhibited the coupling of Go and Gq to alpha 1-ARs by 70% and 80%, respectively. Statistical significance was determined by ANOVA followed by Newman-Keuls test for multiple comparisons. *, p < 0.05 compared with controls. +, p < 0.05 compared with PHE-induced response.

Receptor-activated palmitoylation of Galpha proteins. To further examine the coupling of alpha 1-AR to Galpha proteins, PHE-stimulated palmitoylation of Galpha proteins was assessed. Incubation of aortic membranes with PHE resulted in significant increases in [3H]palmitoylation of Galpha q and Galpha o proteins (Fig. 7) without affecting Galpha s and Galpha i proteins. In addition, pretreatment of membranes with 1 µM of the alpha 1-AR antagonist prazosin blocked the PHE-stimulated incorporation of palmitic acid into Galpha q and Galpha o proteins by 76% and 73%, respectively (Fig. 7). These results therefore support the above data, which indicate that in aorta of 1-month-old Fischer 344 rats, alpha 1-ARs are coupled to both Galpha q and Galpha o proteins.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Palmitoylation of Galpha q and Galpha o proteins in PHE-stimulated aortic membranes. Aortic membranes were incubated with 800 µCi/ml [9,10-3H]palmitic acid, followed by stimulation with buffer or 1 µM PHE. In some experiments, aortic membranes were incubated with 1 µM concentration of the selective alpha 1-AR antagonist prazosin for 5 min before the addition of buffer or PHE. The membranes were solubilized and subjected to immunoprecipitation with antisera directed against a G protein alpha  subunit (1:200 dilution). The radioactivity in the immunoprecipitates was measured. Data represent mean ± standard error of determinations obtained from four animals. PHE stimulation caused significant increases in the palmitoylation of Galpha q and Galpha o proteins as determined by ANOVA followed by Newman-Keuls test for multiple comparisons. *, p < 0.05 compared with controls. +, p < 0.05 compared with PHE-induced response.

    Discussion
Top
Summary
Introduction
Procedures
Results
Discussion
References

Activation of PLC and increased intracellular Ca2+ are important elements of alpha 1-AR-mediated signaling, which result in the contractile response of vascular smooth muscle (20, 21). Despite considerable progress in elucidating the structure and signaling mechanisms of alpha 1-ARs, it is not clear which G protein or proteins are responsible for alpha 1-AR-mediated effects in blood vessels. Many G protein-coupled receptors were shown to activate PLC and increase the intracellular concentration of inositol-(1,4,5)-trisphosphate that eventually lead to vasoconstriction. Two alpha 1-AR-mediated pathways are known to activate PLC and to produce vascular contraction based on their sensitivity to PTX (5, 22). The alpha 1a, alpha 1b, and alpha 1d subtypes of the alpha 1-AR have been shown to activate PLC in transfected COS-7 cells via coupling to the PTX-insensitive G proteins Gqalpha /G11alpha (5). On the other hand, several studies have shown that PTX pretreatment only partially inhibits alpha 1-AR-mediated contraction in blood vessels (6, 7), implicating the existence of alpha 1-ARs that are linked to a PTX-sensitive G protein in vessels. Galpha o protein was proposed to be that PTX-sensitive G protein based on the observation that alpha 1b-ARs, expressed in Xenopus laevis oocytes, use Go protein in activating PLC-mediated Cl- current (22, 23).

The current study confirms the observation that PTX partially inhibits both alpha 1-AR-elicited contraction and IP accumulation in the aorta and suggests that both PTX-sensitive and -insensitive G proteins are involved in alpha 1-AR-mediated signal transduction in vascular smooth muscle. To identify these G proteins, we coimmunoprecipitated alpha 1-ARs with their associated G proteins in the rat aorta. Specific antiserum directed against Galpha q protein coimmunoprecipitated alpha 1-ARs that are specifically labeled by [125I]HEAT, suggesting a linkage between alpha 1-AR and Galpha q protein. Antiserum specific for Galpha o also coimmunoprecipitated [125I]HEAT binding sites, indicating that endogenous alpha 1-ARs in aorta membranes also couple to Galpha o. These data are therefore in agreement with previous studies that indicated functional coupling between alpha 1-ARs and Galpha q in transfected cells (5) and between alpha 1b-AR and Galpha o in X. laevis oocytes that express these proteins (22). In the current study, functional relevance of these linkages is also supported by the ability of the alpha 1-AR agonist PHE to increase the coupling of labeled receptors with both Galpha q and Galpha o proteins and to stimulate palmitoylation of Galpha q and Galpha o proteins in aortic membranes in a prazosin-sensitive manner. Palmitoylation of G protein alpha  subunits is a reversible post-translational modification that is regulated by receptor stimulation (24-26). No linkage was detected between alpha 1-AR and Gs or Gi proteins using either coimmunoprecipitation or the palmitoylation approach. Thus, the data suggest that Go, not Gi, is responsible for the PTX-sensitive responses to alpha 1-AR stimulation in aorta of the 1-month-old Fischer 344 rat.

It has been shown that rat aorta express three alpha 1-AR subtypes: alpha 1a-, alpha 1b-, and alpha 1d-ARs (1, 2). The expression level of these subtypes change with age, coincident with changes in the magnitude of aortic contraction (9, 10). This raises questions about possible differences in the functional roles of the alpha 1-AR subtypes. Although several studies have shown that the three subtypes are capable of stimulating the same signal transduction pathways when they are expressed in cultured cells (3, 4), data from the current study indicate that antisera directed against alpha 1a- and alpha 1d-ARs coimmunoprecipitated Galpha q protein, whereas anti-alpha 1b-AR antiserum coimmunoprecipitated both Galpha q and Galpha o proteins. Furthermore, stimulation of alpha 1-AR with PHE elicited an increase in the coupling of alpha 1-ARs to both Galpha q and Galpha o proteins. Because G proteins determine the specificity and functional diversity of downstream intracellular effectors, identification of the interaction of a particular alpha 1-AR subtype with its G proteins represents an important step in unraveling the signal transduction cascades by which specific alpha 1-AR subtypes exert their effects.

In summary, the current results suggest that alpha 1-ARs are coupled to the PTX-insensitive Galpha q and the PTX-sensitive Galpha o in aorta derived from 1-month-old Fischer 344 rat. These G proteins therefore seem to couple to PLC and to mediate alpha 1-AR-stimulated contraction. It has been shown that the three subtypes of the alpha 1-AR activate PLC and cause increases in inositol trisphosphate level through Galpha q/Galpha 11 proteins (5). This and a previous study (22) demonstrate that alpha 1b-ARs stimulate PLC by coupling, in addition, to the PTX-sensitive Galpha o protein. The ultimate definition of the coupling of alpha 1-AR subtypes with specific Galpha proteins will help to understand the functional roles of the different alpha 1-AR subtypes. This study for the first time demonstrates the specific coupling between alpha 1-AR subtypes and Galpha proteins in vascular smooth muscle membranes and implicates these G proteins in coupling of alpha 1-AR subtypes to the contractile response elicited by alpha 1-AR stimulation in 1-month-old Fischer 344 rat aorta.

    Acknowledgments

The authors thank Dr. H. Ongun Onaran for critical review of the manuscript.

    Footnotes

Received March 31, 1997; Accepted September 9, 1997

   This work was supported by the American Heart Association, Southeastern Pennsylvania and Delaware Affiliates; United States Public Health Service Grants AG07700, AG14510, and AG13282 (Nathan Shock Center of Excellence); Allegheny Health Education and Research Foundation; and Turkish Scientific Council Grant TUBITAK-SBAG 1634.

Send reprint requests to: Eitan Friedman, Ph.D., Division of Molecular Pharmacology, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, 3200 Henry Avenue, Philadelphia, PA 19129. E-mail: friedmane{at}auhs.edu

    Abbreviations

AR, adrenoceptor; PHE, phenylephrine; NE, norepinephrine; IP, inositol phosphate; PTX, pertussis toxin; PLC, phospholipase C; [125I]HEAT, 2-[beta -(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl]tetralone; PSS, physiological salt solution; PBS, phosphate-buffered saline; TBS, Tween-20 containing phosphate-buffered saline; SDS, sodium dodecyl sulfate; ECL, enhanced chemiluminescence; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; ANOVA, analysis of variance.

    References
Top
Summary
Introduction
Procedures
Results
Discussion
References

1. Ping, P. and J. E. Faber. Characterization of alpha 1-adrenoceptor gene expression in arterial and venous smooth muscle. Am. J. Physiol.  265:H1501-H1509 (1993)[Abstract/Free Full Text].
2. Piascik, M. T., M. S. Smith, E. E. Soltis, and D. M. Perez. Identification of the mRNA for the novel alpha 1d-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle. Mol. Pharmacol.  46:30-40 (1994)[Abstract].
3. Minneman, K. P. and T. A. Esbenshade. alpha 1-Adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol.  34:117-133 (1994)[Medline].
4. Bylund, D. B., D. C. Eikenberg, J. P. Hieble, S. Z. Salomon, R. L. Lefkowitz, K. P. Minneman, P. B. Molinof, R. R. Ruffolo, and U. Trendelenburg. IV. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev.  46:121-136 (1994)[Medline].
5. Wu, D, A. Katz, A. H. Lee, and M. I. Simon. Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha  subunits of Gq family. J. Biol. Chem.  36:25798-25802 (1992).
6. Boonen, H. C. M. and J. G. R. De Mey. G-proteins are involved in contractile responses of isolated mesenteric resistance arteries to agonists. Naunyn-Schmiedeberg`s Arch. Pharmacol.  342:462-468 (1990)[Medline].
7. Nichols, A. J., E. D. Motley, and R. R. Ruffolo. Effect of pertussis toxin treatment on postjunctional alpha-1 and alpha-2 adrenoceptor function in the cardiovascular system of the pithed rat. J. Pharmacol. Exp. Ther.  249:203-209 (1989)[Abstract/Free Full Text].
8. Liebau, S., J. Hohlfeld, and U. Förstermann. The inhibition of alpha 1-adrenoceptor-mediated contractions of rabbit pulmonary artery by Ca2+-withdrawal, pertussis toxin and N-ethylmaleimide is dependent on agonist intrinsic efficacy. Naunyn-Schmiedeberg`s Arch. Pharmacol.  339:496-502 (1989)[Medline].
9. Gurdal, H., G. Cai, and M. D. Johnson. Alpha1 adrenoceptor responsiveness in the aging aorta. Eur. J. Pharmacol.  274:117-123 (1995)[Medline].
10. Gurdal, H., N. Tilakaratne, R. D. Brown, M. Fonseca, E. Friedman, and M. D. Johnson. The expression of alpha-1 adrenoceptor subtypes changes in the rat aorta. J. Pharmacol. Exp. Ther.  275:1656-1662 (1995)[Abstract/Free Full Text].
11. Wanstall, J. C. and S. R. O'Donnell. Inhibition of norepinephrine contractions by diltiazem on aorta and pulmonary artery from young and aged rats: influence of alpha-adrenoceptor reserve. J. Pharmacol. Exp. Ther.  245:1016-1020 (1988)[Abstract/Free Full Text].
12. Kendall, D. A. and S. J. Hill. Measurement of [3H]inositol phospholipid turnover, in Methods in Neurotransmitter Receptor Analysis (H. I. Yamamura, S. J Enna and M. J. Kuhar, eds.). Raven Press, New York, 69-92 (1990).
13. Gurdal, H., E. Friedman, and M. D. Johnson. Effects of dietary restriction on the change in aortic alpha 1-adrenoceptor mediated responses during aging in Fischer 344 rats. J. Gerontol.  50A:B67-B71 (1995).
14. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.  72:248-254 (1976)[Medline].
15. Gurdal, H., E. Friedman, and M. D. Johnson. beta -Adrenoceptor-Galpha s coupling decreases with age in rat aorta. Mol. Pharmacol.  47:772-778 (1995)[Abstract].
16. Law, S. F., D. Manning, and T. Reisine. Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J. Biol. Chem.  266:17885-17897 (1991)[Abstract/Free Full Text].
17. Fonseca, M. I., D. Button, and R. D. Brown. Agonist regulation of alpha 1b-adrenergic receptor subcellular distribution and function. J. Biol. Chem.  270:8902-8909 (1995)[Abstract/Free Full Text].
18. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.)  229:680-685 (1970).
19. Johnson, M. D., Y. G. Zhou, E. Friedman, and J. Roberts. Expression of G protein subunits in the aging cardiovascular system. J. Gerontol.  50:B14-B19 (1995).
20. Cauvin, C. and S. Malik. Induction of Ca++ influx and intracellular Ca++ release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of alpha-1 receptors. J. Pharmacol. Exp. Ther.  238:224-231 (1984)[Abstract/Free Full Text].
21. Suematsu, E., M. Hirata, T. Hashimato, and H. Kuriyama. Inositol 1,4,5-trisphosphate releases Ca2+ from intracellular store sites in skinned single cells of porcine coronary artery. Biochem. Biophys. Res. Commun.  120:481-485 (1984)[Medline].
22. Blitzer, R. D. Omri, M. De Vivo, D. J. Carty, R. T. Premon, J. Codina, L. Brinbaumer, S. Cotecchia, M. G. Caron, R. J. Lefkowitz, E. M. Landau, and R. Iyengar. Coupling of the expressed alpha 1B-adrenergic receptor to the phospholipase C pathway in Xenopus oocytes: the role of Go. J. Biol. Chem.  268:7532-7537 (1993)[Abstract/Free Full Text].
23. Padrell, E., D. J. Carty, T. M. Moriarty, J. D. Hildebrant, E. M. Landau, and R. Iyengar. Two forms of bovine brain Go that stimulate the inositol trisphosphate-mediated Cl- currents in Xenopus oocytes: distinct guanine nucleotide binding properties. J. Biol. Chem.  266:9771-9777 (1991)[Abstract/Free Full Text].
24. Casey, P. J. Protein lipidation in cell signaling. Science (Washington D. C.)  268:221-225 (1995)[Abstract/Free Full Text].
25. Wedegaertner, P. B., P. T. Wilson, and H. R. Bourne. Lipid modifications of trimeric G proteins. J. Biol. Chem.  270:503-506 (1995)[Free Full Text].
26. Mumby, S. M., C. Kleuss, and A. G. Gilman. Receptor regulation of G-protein palmitoylation. Proc. Natl. Acad. Sci. USA  91:2800-2804 (1994)[Abstract/Free Full Text].


0026-895X/97/061064-07$3.00/0
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Circ. Res.Home page
J. O-Uchi, H. Sasaki, S. Morimoto, Y. Kusakari, H. Shinji, T. Obata, K. Hongo, K. Komukai, and S. Kurihara
Interaction of {alpha}1-Adrenoceptor Subtypes With Different G Proteins Induces Opposite Effects on Cardiac L-type Ca2+ Channel
Circ. Res., June 6, 2008; 102(11): 1378 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Gallego, R. Setien, L. Puebla, M. d. C. Boyano-Adanez, E. Arilla, and O. Casis
{alpha}1-Adrenoceptors stimulate a G{alpha}s protein and reduce the transient outward K+ current via a cAMP/PKA-mediated pathway in the rat heart
Am J Physiol Cell Physiol, March 1, 2005; 288(3): C577 - C585.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Barki-Harrington, C. Perrino, and H. A Rockman
Network integration of the adrenergic system in cardiac hypertrophy
Cardiovasc Res, August 15, 2004; 63(3): 391 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Papoucheva, A. Dumuis, M. Sebben, D. W. Richter, and E. G. Ponimaskin
The 5-Hydroxytryptamine(1A) Receptor Is Stably Palmitoylated, and Acylation Is Critical for Communication of Receptor with Gi Protein
J. Biol. Chem., January 30, 2004; 279(5): 3280 - 3291.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Vicentic, A. Robeva, G. Rogge, M. Uberti, and K. P. Minneman
Biochemistry and Pharmacology of Epitope-Tagged alpha 1-Adrenergic Receptor Subtypes
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 58 - 65.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. M. Seasholtz, G. Cai, H.-Y. Wang, and E. Friedman
Signal Transduction in Smooth Muscle: Selected Contribution: Effects of ischemia-reperfusion on vascular contractility and {alpha}1-adrenergic-receptor signaling in the rat tail artery
J Appl Physiol, August 1, 2001; 91(2): 1004 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Guimaraes and D. Moura
Vascular Adrenoceptors: An Update
Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. S. S. Chang, J. P. Tam, and E. Sanders-Bush
Dissecting Intracellular Signaling Pathways with Membrane-Permeable Peptides
Sci. Signal., August 29, 2000; 2000(47): pl1 - pl1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Chen and D. R. Manning
Regulation of Galpha i Palmitoylation by Activation of the 5-Hydroxytryptamine-1A Receptor
J. Biol. Chem., July 28, 2000; 275(31): 23516 - 23522.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available